IP Health BLOG
IPHealthBlog.com is a resource of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, providing information about notable IP issues relating to health and medicine, including pharmaceuticals, biologics, medical devices, digital health, fitness, wellness, and nutrition, as well as related FDA rulings and guidance. The blog is not legal advice and does not indicate the views of Finnegan or any Finnegan attorney regarding whether any particular case was correctly or incorrectly decided.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.